These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37296313)

  • 21. The use of NAMs and omics data in risk assessment.
    ; Miccoli A; Marx-Stoelting P; Braeuning A
    EFSA J; 2022 Dec; 20(Suppl 2):e200908. PubMed ID: 36531284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation adverse outcome pathways (AOPs) are on the horizon: advancing radiation protection through an international Horizon-Style exercise.
    Burtt JJ; Leblanc J; Randhawa K; Ivanova A; Rudd MA; Wilkins R; Azzam EI; Hecker M; Horemans N; Vandenhove H; Adam-Guillermin C; Armant O; Klokov D; Audouze K; Kaiser JC; Moertl S; Lumniczky K; Tanaka IB; Yamada Y; Hamada N; Al-Nabulsi I; Preston RJ; Bouffler S; Applegate K; Cool D; Beaton D; Tollefsen KE; Garnier-Laplace J; Laurier D; Chauhan V
    Int J Radiat Biol; 2022; 98(12):1763-1776. PubMed ID: 36067511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus recommendations to promote and advance predictive systems toxicology and toxicogenomics.
    Waters M; Yauk C
    Environ Mol Mutagen; 2007 Jun; 48(5):400-3. PubMed ID: 17567851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
    Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
    PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of omics data in regulatory toxicology: report of an international BfR expert workshop.
    Marx-Stoelting P; Braeuning A; Buhrke T; Lampen A; Niemann L; Oelgeschlaeger M; Rieke S; Schmidt F; Heise T; Pfeil R; Solecki R
    Arch Toxicol; 2015 Nov; 89(11):2177-84. PubMed ID: 26486796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are we closer to the vision? A proposed framework for incorporating omics into environmental assessments.
    Martyniuk CJ
    Environ Toxicol Pharmacol; 2018 Apr; 59():87-93. PubMed ID: 29549817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Framework for the quality assurance of 'omics technologies considering GLP requirements.
    Kauffmann HM; Kamp H; Fuchs R; Chorley BN; Deferme L; Ebbels T; Hackermüller J; Perdichizzi S; Poole A; Sauer UG; Tollefsen KE; Tralau T; Yauk C; van Ravenzwaay B
    Regul Toxicol Pharmacol; 2017 Dec; 91 Suppl 1(Suppl 1):S27-S35. PubMed ID: 28987912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status and future challenges of genotoxicity OECD Test Guidelines for nanomaterials: a workshop report.
    Doak SH; Andreoli C; Burgum MJ; Chaudhry Q; Bleeker EAJ; Bossa C; Domenech J; Drobne D; Fessard V; Jeliazkova N; Longhin E; Rundén-Pran E; Stępnik M; El Yamani N; Catalán J; Dusinska M
    Mutagenesis; 2023 Aug; 38(4):183-191. PubMed ID: 37234002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing chemical carcinogenicity: hazard identification, classification, and risk assessment. Insight from a Toxicology Forum state-of-the-science workshop.
    Felter SP; Bhat VS; Botham PA; Bussard DA; Casey W; Hayes AW; Hilton GM; Magurany KA; Sauer UG; Ohanian EV
    Crit Rev Toxicol; 2021 Sep; 51(8):653-694. PubMed ID: 35239444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.
    Luebke RW; Holsapple MP; Ladics GS; Luster MI; Selgrade M; Smialowicz RJ; Woolhiser MR; Germolec DR
    Toxicol Sci; 2006 Nov; 94(1):22-7. PubMed ID: 16882865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse outcome pathways: From research to regulation scientific workshop report.
    Kleinstreuer NC; Sullivan K; Allen D; Edwards S; Mendrick DL; Embry M; Matheson J; Rowlands JC; Munn S; Maull E; Casey W
    Regul Toxicol Pharmacol; 2016 Apr; 76():39-50. PubMed ID: 26774756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials.
    Martens M; Verbruggen T; Nymark P; Grafström R; Burgoon LD; Aladjov H; Torres Andón F; Evelo CT; Willighagen EL
    Front Genet; 2018; 9():661. PubMed ID: 30622555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a role for the adverse outcome pathway framework to support radiation protection?
    Chauhan V; Said Z; Daka J; Sadi B; Bijlani D; Marchetti F; Beaton D; Gaw A; Li C; Burtt J; Leblanc J; Desrosiers M; Stuart M; Brossard M; Vuong NQ; Wilkins R; Qutob S; McNamee J; Wang Y; Yauk C
    Int J Radiat Biol; 2019 Feb; 95(2):225-232. PubMed ID: 30373433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of AOPs to assist regulatory assessment of chemical risks - Case studies, needs and recommendations.
    Bajard L; Adamovsky O; Audouze K; Baken K; Barouki R; Beltman JB; Beronius A; Bonefeld-Jørgensen EC; Cano-Sancho G; de Baat ML; Di Tillio F; Fernández MF; FitzGerald RE; Gundacker C; Hernández AF; Hilscherova K; Karakitsios S; Kuchovska E; Long M; Luijten M; Majid S; Marx-Stoelting P; Mustieles V; Negi CK; Sarigiannis D; Scholz S; Sovadinova I; Stierum R; Tanabe S; Tollefsen KE; van den Brand AD; Vogs C; Wielsøe M; Wittwehr C; Blaha L
    Environ Res; 2023 Jan; 217():114650. PubMed ID: 36309218
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.